Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort.

@article{Wright2009ProstateCS,
  title={Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort.},
  author={Jonathan L. Wright and Claudia A. Salinas and Daniel W. Lin and Suzanne Kolb and Joseph S Koopmeiners and Ziding Feng and Janet L. Stanford},
  journal={The Journal of urology},
  year={2009},
  volume={182 6},
  pages={2702-7}
}
PURPOSE Reports of biochemical recurrence after prostate cancer primary therapy show differences between Gleason 4 + 3 and 3 + 4 tumors. To our knowledge these findings have not been explored for prostate cancer specific mortality. In this population based cohort we determined prostate cancer outcomes at different Gleason scores, particularly the different Gleason 7 patterns. MATERIALS AND METHODS Men 40 to 64 years old who were diagnosed with prostate cancer between 1993 and 1996 in King… CONTINUE READING